The authors regret that the printed version of the above article contained an inadvertent error where a wrong tumor xenograft study was represented due to a mistaken labeling of PC3 prostate lines in another file. We have now repeated the in vivo experiments with PAICS knockdown cells and with a non-targeting shRNA as a control, and added the correct Figures 3E and F.
No takes yet. Share an insight, caveat, or question.
Chakravarthi et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: